Northern Trust’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.1M | Buy |
1,914,895
+208,788
| +12% | +$2.86M | ﹤0.01% | 1484 |
|
|
2026
Q1 | $21.2M | Buy |
1,706,107
+159,760
| +10% | +$2.15M | ﹤0.01% | 1646 |
|
|
2025
Q4 | $19.5M | Sell |
1,546,347
-81,925
| -5% | -$937K | ﹤0.01% | 1677 |
|
|
2025
Q3 | $16.3M | Buy |
1,628,272
+17,597
| +1% | +$158K | ﹤0.01% | 1826 |
|
|
2025
Q2 | $13M | Sell |
1,610,675
-97,952
| -6% | -$738K | ﹤0.01% | 1913 |
|
|
2025
Q1 | $14.3M | Sell |
1,708,627
-68,656
| -4% | -$573K | ﹤0.01% | 1833 |
|
|
2024
Q4 | $14.1M | Buy |
1,777,283
+156,699
| +10% | +$1.31M | ﹤0.01% | 1926 |
|
|
2024
Q3 | $13.5M | Buy |
1,620,584
+367,732
| +29% | +$2.88M | ﹤0.01% | 1883 |
|
|
2024
Q2 | $7.96M | Sell |
1,252,852
-14,332
| -1% | -$91K | ﹤0.01% | 2122 |
|
|
2024
Q1 | $7.68M | Sell |
1,267,184
-53,451
| -4% | -$301K | ﹤0.01% | 2215 |
|
|
2023
Q4 | $8.02M | Buy |
1,320,635
+113,872
| +9% | +$507K | ﹤0.01% | 2215 |
|
|
2023
Q3 | $5.09M | Buy |
1,206,763
+16,935
| +1% | +$63.2K | ﹤0.01% | 2432 |
|
|
2023
Q2 | $3.69M | Buy |
1,189,828
+157,943
| +15% | +$336K | ﹤0.01% | 2668 |
|
|
2023
Q1 | $1.43M | Buy |
1,031,885
+4,768
| +0.5% | +$9.49K | ﹤0.01% | 3089 |
|
|
2022
Q4 | $2.04M | Sell |
1,027,117
-15,432
| -1% | -$34.6K | ﹤0.01% | 2982 |
|
|
2022
Q3 | $2.11M | Sell |
1,042,549
-7,839
| -0.7% | -$22K | ﹤0.01% | 2990 |
|
|
2022
Q2 | $3.34M | Buy |
1,050,388
+24,593
| +2% | +$89.1K | ﹤0.01% | 2766 |
|
|
2022
Q1 | $4.28M | Sell |
1,025,795
-70,072
| -6% | -$310K | ﹤0.01% | 2670 |
|
|
2021
Q4 | $5.25M | Sell |
1,095,867
-51,375
| -4% | -$256K | ﹤0.01% | 2649 |
|
|
2021
Q3 | $6.13M | Sell |
1,147,242
-49,738
| -4% | -$250K | ﹤0.01% | 2603 |
|
|
2021
Q2 | $6.13M | Sell |
1,196,980
-78,326
| -6% | -$445K | ﹤0.01% | 2723 |
|
|
2021
Q1 | $8.58M | Sell |
1,275,306
-121,155
| -9% | -$671K | ﹤0.01% | 2390 |
|
|
2020
Q4 | $6.38M | Sell |
1,396,461
-53,348
| -4% | -$236K | ﹤0.01% | 2535 |
|
|
2020
Q3 | $5.63M | Sell |
1,449,809
-71,551
| -5% | -$306K | ﹤0.01% | 2463 |
|
|
2020
Q2 | $7.24M | Sell |
1,521,360
-33,047
| -2% | -$136K | ﹤0.01% | 2297 |
|
|
2020
Q1 | $5.41M | Buy |
1,554,407
+16,083
| +1% | +$68.1K | ﹤0.01% | 2262 |
|
|
2019
Q4 | $7.42M | Buy |
1,538,324
+185,740
| +14% | +$646K | ﹤0.01% | 2370 |
|
|
2019
Q3 | $3.92M | Buy |
1,352,584
+151,846
| +13% | +$530K | ﹤0.01% | 2683 |
|
|
2019
Q2 | $8.61M | Buy |
1,200,738
+14,961
| +1% | +$153K | ﹤0.01% | 2242 |
|
|
2019
Q1 | $16.8M | Sell |
1,185,777
-10,938
| -0.9% | -$145K | ﹤0.01% | 1834 |
|
|
2018
Q4 | $16.2M | Sell |
1,196,715
-20,034
| -2% | -$361K | ﹤0.01% | 1752 |
|
|
2018
Q3 | $27M | Buy |
1,216,749
+44,457
| +4% | +$936K | 0.01% | 1536 |
|
|
2018
Q2 | $19.2M | Buy |
+1,172,292
| New | +$20.6M | ﹤0.01% | 1808 |
|
Other funds holding AMRX
TGA
RCMNY
Northern Trust's AMRX Position: Q2 2026 in Review
Northern Trust increased its Amneal Pharmaceuticals (AMRX) stake by 12% in Q2 2026, buying an estimated $2.86M and bringing the position to 1,914,895 shares worth $33.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1484.
Northern Trust first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- Northern Trust held 1,914,895 shares of Amneal Pharmaceuticals worth $33.1M as of Q2 2026.
- Northern Trust bought 208,788 Amneal Pharmaceuticals shares in Q2 2026, an estimated $2.86M.
- Amneal Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #1484 holding.
- Northern Trust first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.